The lived experience of interferon-free treatments for hepatitis C: A thematic analysis (2016)
Journal Article
Whiteley, D., Whittaker, A., Elliott, L., & Cunningham-Burley, S. (2016). The lived experience of interferon-free treatments for hepatitis C: A thematic analysis. International Journal of Drug Policy, 38, 21-28. https://doi.org/10.1016/j.drugpo.2016.10.013

Background: International discourse concerning the evolution in hepatitis C virus (HCV) therapy has tended to focus on improving outcomes, shortened treatment length and reduced side-effects of interferon-free regimens. How these treatments are being... Read More about The lived experience of interferon-free treatments for hepatitis C: A thematic analysis.

Health-Related Quality of Life for individuals with hepatitis C: A narrative review (2015)
Journal Article
Whiteley, D., Elliott, L., Cunningham-Burley, S., & Whittaker, A. (2015). Health-Related Quality of Life for individuals with hepatitis C: A narrative review. International Journal of Drug Policy, 26(10), 936-949. https://doi.org/10.1016/j.drugpo.2015.04.019

BACKGROUND The assessment of Health-Related Quality of Life (HRQoL) in hepatitis C (HCV) infected individuals continues to gain importance. However, rarely do reviews of this literature consider quantitative and qualitative accounts of HRQoL colle... Read More about Health-Related Quality of Life for individuals with hepatitis C: A narrative review.